Sale!

KRT17 Gene Pachyonychia Congenita Type 2 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The KRT17 Gene Pachyonychia Congenita Type 2 NGS Genetic DNA Test is a comprehensive genetic analysis that identifies mutations in the KRT17 gene responsible for Pachyonychia Congenita Type 2, a rare inherited skin disorder. This advanced next-generation sequencing test provides definitive diagnosis for patients experiencing painful palmoplantar keratoderma, severe nail dystrophy, and oral leukokeratosis. By detecting specific genetic mutations, the test enables accurate diagnosis, appropriate treatment planning, and genetic counseling for affected families. The test costs $500 USD and utilizes state-of-the-art NGS technology to deliver reliable results within 3-4 weeks, helping dermatologists and genetic specialists provide targeted care for this challenging condition.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

KRT17 Gene Pachyonychia Congenita Type 2 NGS Genetic DNA Test

Comprehensive Genetic Testing for Inherited Skin and Nail Disorders

The KRT17 Gene Pachyonychia Congenita Type 2 NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare dermatological conditions. This advanced genetic test specifically targets mutations in the KRT17 gene, which encodes keratin 17—a crucial structural protein essential for maintaining the integrity of skin, nails, and mucous membranes. When mutations occur in this gene, they disrupt normal cellular function, leading to the characteristic symptoms of Pachyonychia Congenita Type 2.

What This Test Measures and Detects

Our sophisticated Next-Generation Sequencing (NGS) technology comprehensively analyzes the entire KRT17 gene to identify pathogenic variants responsible for Pachyonychia Congenita Type 2. The test specifically detects:

  • Point mutations affecting keratin 17 protein structure
  • Insertion and deletion variants disrupting gene function
  • Missense mutations altering amino acid sequences
  • Frameshift mutations causing premature protein termination
  • Specific genetic markers associated with disease severity

Who Should Consider This Genetic Test

This specialized genetic test is recommended for individuals presenting with the following clinical symptoms:

  • Painful Palmoplantar Keratoderma: Thickened skin on palms and soles causing significant discomfort
  • Severe Nail Dystrophy: Abnormal nail growth, thickening, and discoloration
  • Oral Leukokeratosis: White patches inside the mouth and on the tongue
  • Follicular Keratosis: Rough, bumpy skin on elbows, knees, and buttocks
  • Family History: Individuals with relatives diagnosed with Pachyonychia Congenita
  • Unexplained Skin Conditions: Patients with treatment-resistant dermatological symptoms

Clinical Benefits of Genetic Testing

Undergoing the KRT17 genetic test provides numerous advantages for patients and healthcare providers:

  • Definitive Diagnosis: Eliminates diagnostic uncertainty and provides clear genetic confirmation
  • Personalized Treatment: Enables targeted therapeutic approaches based on specific mutation type
  • Genetic Counseling: Facilitates informed family planning decisions and risk assessment
  • Early Intervention: Allows for proactive management of symptoms before they become severe
  • Research Contribution: Helps advance scientific understanding of rare genetic disorders
  • Psychological Relief: Provides answers and reduces the emotional burden of undiagnosed conditions

Understanding Your Test Results

Our comprehensive genetic report provides clear, actionable information:

  • Positive Result: Identifies a pathogenic mutation in the KRT17 gene, confirming Pachyonychia Congenita Type 2 diagnosis
  • Negative Result: No disease-causing mutations detected, though clinical correlation with symptoms is essential
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical evaluation
  • Carrier Status: Determines if individuals carry the mutation without showing symptoms

All results include detailed interpretation by our board-certified genetic specialists, with specific recommendations for clinical management and follow-up care.

Test Pricing and Availability

Test Name Discount Price Regular Price
KRT17 Gene Pachyonychia Congenita Type 2 NGS Genetic DNA Test $500 USD $700 USD

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures accessible testing for patients nationwide.

Sample Collection and Processing

Our test requires minimal sample collection through one of the following methods:

  • Blood sample drawn by certified phlebotomist
  • Extracted DNA from previous genetic testing
  • One drop of blood on FTA card for convenient at-home collection

Turnaround time for results is typically 3 to 4 weeks from sample receipt at our CLIA-certified laboratory.

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session to create detailed family pedigree
  • Discussion of testing implications with healthcare provider
  • Informed consent understanding the benefits and limitations of genetic testing

Take Control of Your Genetic Health Today

Don’t let unexplained skin and nail symptoms affect your quality of life. Our KRT17 Gene Pachyonychia Congenita Type 2 NGS Genetic DNA Test provides the answers you need for proper diagnosis and management. With our discounted price of $500 USD and nationwide availability, comprehensive genetic testing has never been more accessible.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward definitive diagnosis and personalized care.